For years, the biggest hurdle for digital health and preventative care platforms wasn't consumer demand, it was reimbursement.
If a digital therapeutic or continuous monitoring tool couldn't map to existing CPT insurance codes, platforms were forced to rely entirely on direct-to-consumer cash pay. That capped distribution and limited access to lower-income demographics.
As regulatory frameworks and insurance coverage expand for Remote Physiological Monitoring (RPM) and digital therapies, the commercial playbook for MedTech is shifting rapidly: pmc.ncbi.nlm.nih.gov/articles/PMC...
The most resilient healthtech startups are no longer just building great clinical software; they are designing reimbursement-first workflows from day one.
Are you seeing more healthtech founders build around insurance integration early, or are direct-to-consumer cash models still the preferred entry point?
